Overall, despite the literature so far published seems to report conflicting data, some evidence coming from some retrospective cohort studies provide some data on the effects of maternal alcohol intake during pregnancy and/or breastfeeding. Alcohol use disorder (AUD) during pregnancy and postpartum period may determine the onset of major and/or minor congenital malformations (during the exposition in the first pregnancy trimester), intellectual disability in the newborns exposed throughout pregnancy and the risk of developing a foetal alcohol syndrome (FAS) and foetal alcohol spectrum disorders (FASD). Alcohol use during lactation has also been associated with an increased prevalence of adult deficit hyperactivity disorder (ADHD) and altered infant sleep patterns. Overall, there is little research information and methodologically well-designed clinical studies able to guide clinicians working within Mental Health’s and Drug Addiction’s services regarding clinical decision-making and therapeutic flowchart for the management and treatment of pregnant and/or nursing women affected with AUD. Motivational interviewing and brief interventions have been demonstrated to be more effective than judgmental or punitive approaches in encouraging positive behavioural lifestyle changes. Little evidence is available in the treatment and management of alcohol withdrawal during pregnancy and in the prescription of acamprosate, naltrexone and disulfiram. Overall, the best management approach should be recommended to all clinicians to advise all women who are pregnant or planning a pregnancy the potential risks related to alcohol intake during pregnancy and breastfeeding, the associated risk if a woman is already affected with AUD and she is at-risk to develop alcohol dependence. In particular, women should be recommended that not drinking is the safest option to limit/reduce the risk of fetal malformations, perinatal and/or obstetrician complications and limit the risks on newborns. Similarly, alcohol intake should be greatly avoided during the postpartum period, particularly when the woman decides to breastfeed the newborn. All women should be adequately supported in a non-judgemental manner and help them in the management of alcohol intake throughout the perinatal period.

Alcohol Use Disorders / Orsolini, Laura; Volgare, Rosa; Francesconi, Giulia; Martinotti, Giovanni; Volpe, Umberto. - (2025), pp. 447-466. [10.1007/978-3-031-99720-4_21]

Alcohol Use Disorders

Orsolini, Laura
;
Volgare, Rosa;Francesconi, Giulia;Volpe, Umberto
2025-01-01

Abstract

Overall, despite the literature so far published seems to report conflicting data, some evidence coming from some retrospective cohort studies provide some data on the effects of maternal alcohol intake during pregnancy and/or breastfeeding. Alcohol use disorder (AUD) during pregnancy and postpartum period may determine the onset of major and/or minor congenital malformations (during the exposition in the first pregnancy trimester), intellectual disability in the newborns exposed throughout pregnancy and the risk of developing a foetal alcohol syndrome (FAS) and foetal alcohol spectrum disorders (FASD). Alcohol use during lactation has also been associated with an increased prevalence of adult deficit hyperactivity disorder (ADHD) and altered infant sleep patterns. Overall, there is little research information and methodologically well-designed clinical studies able to guide clinicians working within Mental Health’s and Drug Addiction’s services regarding clinical decision-making and therapeutic flowchart for the management and treatment of pregnant and/or nursing women affected with AUD. Motivational interviewing and brief interventions have been demonstrated to be more effective than judgmental or punitive approaches in encouraging positive behavioural lifestyle changes. Little evidence is available in the treatment and management of alcohol withdrawal during pregnancy and in the prescription of acamprosate, naltrexone and disulfiram. Overall, the best management approach should be recommended to all clinicians to advise all women who are pregnant or planning a pregnancy the potential risks related to alcohol intake during pregnancy and breastfeeding, the associated risk if a woman is already affected with AUD and she is at-risk to develop alcohol dependence. In particular, women should be recommended that not drinking is the safest option to limit/reduce the risk of fetal malformations, perinatal and/or obstetrician complications and limit the risks on newborns. Similarly, alcohol intake should be greatly avoided during the postpartum period, particularly when the woman decides to breastfeed the newborn. All women should be adequately supported in a non-judgemental manner and help them in the management of alcohol intake throughout the perinatal period.
2025
Perinatal Psychopharmacology
9783031997198
9783031997204
File in questo prodotto:
File Dimensione Formato  
ChapterAUD_prepublication_accepted proof.pdf

embargo fino al 31/08/2026

Tipologia: Documento in post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza d'uso: Tutti i diritti riservati
Dimensione 521.02 kB
Formato Adobe PDF
521.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
ChapterAUD_editorial.pdf

Solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza d'uso: Tutti i diritti riservati
Dimensione 293.69 kB
Formato Adobe PDF
293.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/347073
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact